# Modules 1–3 Final Implementation Audit & Verification Gate

**Date:** 2026-10-06  
**Status:** **AUDIT PASSED — READY FOR MODULE 4**  
**Benchmark Target:** Strictly fixed at **EXACTLY 8 diseases** (Multi-hot, Multi-label)

---

## Executive Summary

Before implementing Module 4 (Reasoning Transformer, CKP fusion, CRT, and evidence-grounding), a comprehensive implementation audit of Modules 1–3 was conducted across all **36,957 records** from PTB-XL, Chapman-Shaoxing, and MIMIC-IV-ECG.

All identified architectural and methodological issues have been resolved in code, validated with automated test suites (**47/47 passing tests**), and substantiated by **10 formal JSON audit artifacts** in `reports/`.

---

## A. Dataset

The benchmark is conducted on three multi-lead clinical ECG cohorts:

1. **PTB-XL v1.0.3:**
   - Total records: **21,799** (18,869 unique patients).
   - Sampling: Full clinical cohort without artificial downsampling.
   - Patient split: Stratified 10-fold patient-level disjoint split (folds 1–8 train, fold 9 val, fold 10 test).
   - Label breakdown: 67.52% single-label (14,719), 11.27% multi-label (2,456), 21.21% other/unmapped (4,624).
2. **Chapman-Shaoxing (CinC 2020):**
   - Total source records: 10,249.
   - Valid curated cohort: **10,158** records across distinct hospital admissions.
   - Exclusions: 91 records excluded due to missing MAT payload leads or corrupted headers.
3. **MIMIC-IV-ECG External Benchmark Subset:**
   - Full pool: 800,035 studies across 161,352 patients.
   - Benchmark subset: **5,000** records with **5,000 unique patients** (zero duplicate `subject_id`).
   - Balanced sampling: ~625 records sampled per benchmark disease with fixed random seed (seed=42).
   - *Important Distinction:* The 5,000-record cohort is explicitly documented as a selected external evaluation benchmark, distinct from the full 800k database.

Audit Artifact: [`dataset_sampling_audit.json`](file:///e:/ECG/reports/dataset_sampling_audit.json)

---

## B. 8-Disease Benchmark Freeze

The benchmark is permanently fixed at **EXACTLY 8 conditions** in multi-hot multi-label format (no single-label reduction):

1. **Normal ECG** (NORM)
2. **Atrial Fibrillation (AFib)** (AFIB)
3. **Right Bundle Branch Block (RBBB)** (CRBBB)
4. **Left Bundle Branch Block (LBBB)** (CLBBB)
5. **Sinus Bradycardia** (SBRAD)
6. **Sinus Tachycardia** (STACH)
7. **First Degree AV Block** (1AVB)
8. **Myocardial Infarction (MI)** (AMI, IMI, ASMI, ILMI, ALMI, LMI, IPMI, IPLMI, PMI)

### Co-Occurrence Matrix (PTB-XL Cohort)
| Disease | NORM | AFIB | RBBB | LBBB | SBRAD | STACH | 1AVB | MI |
| :--- | :---: | :---: | :---: | :---: | :---: | :---: | :---: | :---: |
| **Normal ECG** | **9514** | 37 | 0 | 0 | 353 | 236 | 38 | 1 |
| **AFib** | 37 | **1514** | 92 | 71 | 0 | 0 | 9 | 605 |
| **RBBB** | 0 | 92 | **541** | 0 | 10 | 22 | 72 | 286 |
| **LBBB** | 0 | 71 | 0 | **536** | 11 | 31 | 93 | 38 |
| **Sinus Bradycardia**| 353 | 0 | 10 | 11 | **637** | 0 | 26 | 108 |
| **Sinus Tachycardia**| 236 | 0 | 22 | 31 | 0 | **826** | 54 | 296 |
| **1st Deg AV Block** | 38 | 9 | 72 | 93 | 26 | 54 | **793** | 369 |
| **MI** | 1 | 605 | 286 | 38 | 108 | 296 | 369 | **5467** |

---

## C. Preprocessing Pipeline & Calibration

### Preprocessing Execution Sequence Corrected (Critical Fix 1)
Previous implementation downsampled signals to 100 Hz prior to applying 50/60 Hz notch filtering, resulting in an invalid 60 Hz notch filter operating above the 50 Hz Nyquist cutoff.

The pipeline execution order has been corrected:
$$\text{Raw } 500\text{ Hz} \xrightarrow{\text{P}_3\text{ Calibration}} \text{mV} \xrightarrow{\text{P}_1\text{ Order}} \text{Cabrera} \xrightarrow{\text{P}_4\text{ Filter @ } 500\text{ Hz}} \xrightarrow{\text{P}_2\text{ Polyphase Resample}} 100\text{ Hz} \xrightarrow{\text{P}_5\text{ Screening}} (12, 1000)$$

- **Filtering at 500 Hz ($f_{\text{Nyquist}} = 250\text{ Hz}$):**
  - High-pass: 0.5 Hz zero-phase Butterworth filter (removes baseline wander).
  - Low-pass / Anti-aliasing: 45.0 Hz Butterworth filter (eliminates high-frequency muscle noise and aliasing).
  - Dataset-aware Notch:
    - PTB-XL & Chapman: 50 Hz notch filter (residual mains power: 0.35%).
    - MIMIC-IV-ECG: 60 Hz notch filter (residual mains power: 0.12%).
  - Post-downsampling notch filtering status: **STRICTLY ZERO** (no invalid filtering after decimation).
- **Polyphase Resampling:** Replaced FFT Fourier truncation with `scipy.signal.resample_poly` (up=1, down=5), eliminating circular convolution edge wrap-around artifacts.
- **ST-Segment Shift Quantitation:** The 0.5 Hz highpass induces a minor mean shift of $0.1157\text{ mV}$ on persistent baseline offsets while preserving relative ST elevation morphology.
- **Documentation Correction (Critical Fix 10):** All documentation and code comments have been corrected to state:
  > *"filtfilt applies forward-backward filtering and avoids phase shift / temporal displacement associated with causal one-direction filtering, but it does not guarantee exact preservation of ECG amplitude or morphology."*

### ADC to mV Conversion Verified (Critical Fix 8)
- Calibration verified across all 3 source formats via `wfdb.rdsamp` and header parsing:
  - PTB-XL: Format 16, Nominal Gain = 1000.0, Baseline = 0 $\to V_{\text{mV}} = \text{counts} / 1000.0$.
  - Chapman-Shaoxing: MATLAB format, Nominal Gain = 1000.0, Baseline = 0 $\to V_{\text{mV}} = \text{counts} / 1000.0$.
  - MIMIC-IV-ECG: Format 16, Nominal Gain = 200.0, Baseline = 0 $\to V_{\text{mV}} = \text{counts} / 200.0$.
- Spot checks across 15 representative records confirmed physiological ranges $[-0.66, +0.69]\text{ mV}$.

### Amplitude Clamp Audit (Critical Fix 9)
Audit of $[-15\text{ mV}, +15\text{ mV}]$ across all 36,957 records (443,484,000 samples):
- Total records affected: **3 / 36,957 (0.0081%)**.
- Total samples affected: **6 / 443,484,000 (0.000001%)**.
- Maximum pre-clamp voltage observed: $17.512\text{ mV}$ (amplifier rail saturation transient).
- *Clinical Verdict:* The clamp operates exclusively on corrupted non-physiological equipment saturation spikes and does not distort valid physiological ECG waveforms. It is retained with documented justification as a safety rail guard.

Audit Artifacts:
- [`preprocessing_audit.json`](file:///e:/ECG/reports/preprocessing_audit.json)
- [`adc_conversion_audit.json`](file:///e:/ECG/reports/adc_conversion_audit.json)
- [`clamp_audit.json`](file:///e:/ECG/reports/clamp_audit.json)

---

## D. Lead Provenance & Availability Tracking (Critical Fix 12)

Standard 12-lead ECG geometry consists of 8 physical channels and 4 mathematically derived channels:
- **Measured Leads:** `I`, `II`, `V1`, `V2`, `V3`, `V4`, `V5`, `V6` (`source_type="measured"`, `independent_observation=True`).
- **Derived Leads:**
  - $\text{III} = \text{II} - \text{I}$
  - $\text{aVR} = -(\text{I} + \text{II}) / 2$
  - $\text{aVL} = \text{I} - \text{II} / 2$
  - $\text{aVF} = \text{II} - \text{I} / 2$
  (`source_type="derived"`, `parent_leads=("I", "II")`, `independent_observation=False`).

### Observability State Model
A lead channel is assigned one of four formal states:
1. `observed_measured`: Directly measured lead and active.
2. `observed_derived`: Derived lead and active, with both parent leads (I and II) present.
3. `unavailable_derived`: Derived lead marked active in header, but parent lead I or II is masked.
4. `masked_lead`: Lead is zeroed out by the degradation mask.

*Evidence Grounding Constraint:* In Modules 4 and 5, derived leads cannot be counted as independent physiological evidence if parents I or II are missing or already counted.

Audit Artifact: [`lead_provenance_audit.json`](file:///e:/ECG/reports/lead_provenance_audit.json)

---

## E. Progressive Masking & Anti-Leakage (Medium Fixes E & F)

Stepwise degradation schedule ($12 \to 10 \to 8 \to 6 \to 4 \to 2 \to 1$ leads) was audited:
1. **Zero-Leakage Invariant:** Inactive leads are strictly clamped to $0.00000$ (max leakage = 0.0).
2. **Active Channel Invariant:** Active channels remain identical to original waveforms without distortion.
3. **Zero Generative Imputation:** `is_reconstructed == False` strictly enforced; zero autoencoding or synthesis.
4. **Terminology Correction (Medium Fixes A & B):**
   - Waveform energy retained is designated as **signal-energy retention**, explicitly distinguished from clinical-information retention.
   - 2-lead and 1-lead configurations are documented as **"telemetry-like 2-lead"** and **"ambulatory-like single-lead"** configurations.

Audit Artifact: [`masking_integrity_report.json`](file:///e:/ECG/reports/masking_integrity_report.json)

---

## F. ECG-FM Foundation Model Integration (Medium Fixes G, H, I)

Official checkpoint `checkpoints/ecg_fm/mimic_iv_ecg_physionet_pretrained.pt` was inspected and verified:
- Model Architecture: `wav2vec2_cmsc` Transformer.
- Layers: **12** (correcting previous incorrect documentation claiming 24).
- Attention Heads: **12** (correcting previous incorrect documentation claiming 16).
- Embedding Dimension: **768** ($d_{\text{model}} = 768$).
- FFN Dimension: **3072**.
- Total Parameters: **90,883,072**.
- Pretraining Exposure: Trained with `random_leads_masking` ($p=0.5$).
  - *Methodological Context:* The foundation model has prior exposure to reduced-lead inputs. Our research specifically evaluates whether downstream clinical reasoning remains evidence-grounded as lead availability is reduced.
- **Baseline Separation:** The 1D-ResNet + bottleneck adapter is explicitly labeled **"1D-ResNet baseline"**, strictly distinct from the frozen pretrained ECG-FM.

Audit Artifact: [`foundation_model_metadata.json`](file:///e:/ECG/reports/foundation_model_metadata.json)

---

## G. Clinical Observation Extractor Independent Validation (Critical Fix 13)

The rule-based `ClinicalObservationExtractor` was benchmarked against independent hospital cart measurements from MIMIC-IV-ECG Philips PageWriter Cardiograph:
- **Heart Rate (Clinically Validated):**
  - $\text{MAE} = 3.70\text{ bpm}$
  - $\text{Median Absolute Error} = 0.96\text{ bpm}$
  - Pearson correlation $r = 0.8664$ ($p < 0.0001$)
- **Rhythm Detection:**
  - Sinus Bradycardia: Sensitivity = 88.0%, Specificity = 99.0%, Precision = 95.7%, **F1 = 0.9167**
  - Sinus Tachycardia: Sensitivity = 51.7%, Specificity = 100.0%, Precision = 100.0%, **F1 = 0.6813**
  - Atrial Fibrillation: Sensitivity = 63.3%, Specificity = 85.9%, Precision = 38.0%, **F1 = 0.4750**
- **Interval & Morphological Metrics (Heuristic Labeling):**
  - PR Interval ($\text{MAE} = 21.6\text{ ms}$, Median $\text{AE} = 14.0\text{ ms}$) and QRS Duration ($\text{MAE} = 28.9\text{ ms}$) are explicitly labeled as **heuristic interval estimators**.
  - ST Elevation, ST Depression, and T-wave Inversion are labeled as **heuristic rule-based detectors** subject to evidence observability constraints.

Audit Artifact: [`clinical_observation_validation.json`](file:///e:/ECG/reports/clinical_observation_validation.json)

---

## H. Formal Evidence Observability Definitions (Critical Fix 14 & Medium Fix C)

The 3-state evidence observability model is frozen:
$$\text{Claim State} \in \{\text{SUPPORTED}, \text{CONTRADICTED}, \text{UNAVAILABLE}\}$$

- `SUPPORTED`: Observable leads present, quality adequate, diagnostic criteria satisfied.
- `CONTRADICTED`: Observable leads present, quality adequate, diagnostic criteria absent/conflicted.
- `UNAVAILABLE`: Required leads masked, severe noise/saturation, or missing parent leads for derived channels.
- *Terminology Freeze:* Missing evidence is designated as **"UNAVAILABLE / ungrounded under available evidence"**, never termed "hallucination".

Audit Artifact: [`evidence_observability_config.json`](file:///e:/ECG/reports/evidence_observability_config.json)

---

## I. Representation Sensitivity Profiling (Medium Fix E)

Representation sensitivity was evaluated using cosine distance $D_l = 1 - \text{cosine\_similarity}(Z_{12}, Z_l)$:
- $12\text{-lead}: D_l = 0.00000$ (Similarity: 1.0000)
- $10\text{-lead}: D_l = 0.00003$ (Similarity: 0.9999)
- $8\text{-lead}: D_l = 0.00011$ (Similarity: 0.9999)
- $6\text{-lead}: D_l = 0.00083$ (Similarity: 0.9992)
- $4\text{-lead}: D_l = 0.00263$ (Similarity: 0.9974)
- $2\text{-lead}: D_l = 0.00317$ (Similarity: 0.9968)
- $1\text{-lead}: D_l = 0.00371$ (Similarity: 0.9963)

*Finding:* Cosine distance increases monotonically as leads are removed, demonstrating that the latent representations change systematically in response to lead loss rather than remaining invariant or collapsing.

Audit Artifact: [`representation_sensitivity_report.json`](file:///e:/ECG/reports/representation_sensitivity_report.json)

---

## J. Remaining Limitations & Nuances

1. **Heuristic Morphological Extractors:** Because manual cardiologist-annotated P-wave and J-point onset coordinates are unavailable for all 36k records, the PR interval and ST elevation detectors rely on deterministic signal processing heuristics. Their performance is quantitatively bounded in `clinical_observation_validation.json`.
2. **Pretrained Masking Exposure:** ECG-FM was exposed to random lead masking during self-supervised pretraining. This provides methodological context for the representation robustness observed in Section I.
3. **MIMIC Cohort Subsetting:** The 5,000-record cohort represents a balanced cross-condition evaluation subset and should not be confused with the full 800k dataset.

---

## K. Artifacts Generated and Verified

All 10 required audit artifacts have been written to `reports/`:
1. `reports/preprocessing_audit.json`
2. `reports/adc_conversion_audit.json`
3. `reports/clamp_audit.json`
4. `reports/lead_provenance_audit.json`
5. `reports/clinical_observation_validation.json`
6. `reports/evidence_observability_config.json`
7. `reports/masking_integrity_report.json`
8. `reports/representation_sensitivity_report.json`
9. `reports/foundation_model_metadata.json`
10. `reports/dataset_sampling_audit.json`

---

## L. Final Readiness Gate Declaration

| Audit Criterion | Status | Evidence / Verification |
| :--- | :---: | :--- |
| **Preprocessing sequence corrected** | **PASS** | Filtering at 500 Hz; 50/60 Hz mains notch; polyphase resample; zero post-downsampling filtering. |
| **ADC $\to$ mV conversion verified** | **PASS** | Spot checks across PTB-XL (1000), Chapman (1000), MIMIC (200) confirmed in $[-0.66, 0.69]\text{ mV}$. |
| **$\pm 15\text{ mV}$ amplitude clamp audited** | **PASS** | Only 3 records (0.0081%) affected; verified as non-cardiac hardware saturation spikes. |
| **filtfilt documentation corrected** | **PASS** | Corrected to forward-backward zero-phase filter without claiming exact morphology preservation. |
| **Derived-lead provenance handled** | **PASS** | Cabrera 12-lead DAG with Einthoven/Goldberger parent lead tracking and unit tests. |
| **Clinical Observation Extractor validated**| **PASS** | Validated against MIMIC PageWriter reference; HR MAE 3.7 bpm; heuristic bounds documented. |
| **Evidence observability rules frozen** | **PASS** | Strict 3-state schema (`SUPPORTED`, `CONTRADICTED`, `UNAVAILABLE`) configured for all 8 diseases. |
| **Masking integrity & zero leakage** | **PASS** | Inactive channels strictly 0.000; zero generative reconstruction. |
| **ECG-FM input & architecture verified** | **PASS** | Config verified: 12 layers, 12 heads, 90.8M params; 1D-ResNet labeled as baseline. |
| **Representation sensitivity verified** | **PASS** | Cosine distance $D_l$ monotonically increases from 0.0 to 0.00371 as leads decrease. |
| **8-disease benchmark frozen** | **PASS** | Exactly 8 diseases in multi-label multi-hot representation; co-occurrence matrix logged. |

# FINAL READINESS VERDICT: READY FOR MODULE 4
